GoodRx Holdings Q2 Adjusted Net Income USD 26.8 Million Vs. IBES Estimate USD 27.2 Million
GDRX•GoodRx reports second-quarter results
Aug. 5 (Reuters) - GoodRx Holdings Q2 revenue USD 200.4 million vs. IBES estimate USD 193.2 million.
- Q2 adjusted EBITDA USD 63.7 million vs. IBES estimate USD 59.8 million
- Q2 adjusted EBITDA margin 31.8%
- Q2 net income USD 8.5 million
